• Home
• About us
• Contact

• News
• People
• Products
• Deals
• Organisations

• » Follow us on twitter!
• » Get Free Newsletter!

Advertisement

Life-Sciences-Europe.com
The European Life Sciences Web Portal

This is a free web portal for the life sciences in Europe and Israel... » read more

• Clarivate Analytics to Acquire Decision Resources for $950m (2020-01-17)
  > Deal expands Life Sciences services and solutions portfolio to enable customers worldwide to accelerate life-changing innovations and improve patient outcomes and access > Accretive to earnings in 2020 with opportunities for significant revenue and cost syner...
• Charles River Labs & Fios Genomics Form a Strategic Alliance (2020-01-16)
  Together, Charles River and Fios Genomics aim to accelerate preclinical discovery and development by turning complex data into actionable information Charles River Laboratories International, Inc. (NYSE: CRL) today announced that it has entered into an exclusi...
• BioNTech to Acquire Neon Therapeutics for $67m in Shares (2020-01-16)
  > Further expands BioNTech’s growing CAR-T and TCR therapy pipeline through addition of neoantigen specific cell therapies, including a T cell therapy targeting shared RAS oncogenes > Accelerates BioNTech’s global expansion by creating a U.S. hub for research an...
• Rafaèle Tordjman Launches Jeito Capital, Raises €200m (2020-01-15)
  Rafaèle Tordjman launches JEITO CAPITAL, a new French and independent investment investor dedicated to biotech and biopharma. The launch is completed by the closing of JEITO I fund's with the support and investment of renowned institutional investors and family off...
• Astellas & Adpaptimmune: Allogenic T-Cell Therapies (2020-01-14)
  - Agreement covers the co-development and co-commercialization of up to three T-cell therapies - - Agreement leverages Astellas’ Universal Donor Cell Platform and Adaptimmune’s stem-cell derived allogeneic T-cell platform - - Astellas will pay Adaptimmune an ...
• Curetis Launches Unyvero LRT Panel for BAL Specimens in U.S. (2020-01-14)
  > Panel also includes atypical pathogens such as Pneumocystis jirovecii > LRT BAL Panel expected to substantially increase total addressable market for Unyvero System in the U.S. Curetis N.V. (the "Company" and, together with its subsidiaries, "Curetis"), a...
• Vivoryon & Nordic Bioscience Enter into R&D Collaboration (2020-01-14)
  Vivoryon Therapeutics AG (Euronext Amsterdam: VVY, ISIN DE0007921835) and Nordic Bioscience, announced today an agreement to collaborate for the clinical development of PQ912 for Alzheimer’s Disease (AD). In addition to taking on the role as CRO (Clinical Research ...
• MorphoSys & Incyte: up to $1.85b Agreement for Tafasitamab (2020-01-13)
  - MorphoSys and Incyte to co-commercialize tafasitamab in the U.S. - Incyte has exclusive commercialization rights outside of the U.S. - MorphoSys and Incyte to host joint conference call on January 13, 2020 at 7:00am PST / 4:00pm CET MorphoSys AG (FSE:...
• Roche & Illumina: 15-Year Oncology NGS Partnership (2020-01-13)
  > Partnership to leverage Illumina’s extensive decentralised installed base with Roche’s expertise in assay development and to provide broad access to clinical oncology next-generation sequencing > Comprehensive genomic testing improves clinical decision making ...
• KCR Appoints Bryan Katz as CCO, Based in Boston (2020-01-13)
  KCR, the international clinical development solutions provider, announced today that Bryan Katz has joined the organization in the role of Chief Commercial Officer. Mr. Katz will oversee the expansion of KCR global commercial solutions and partnerships. Mr. Katz...

» Show all News!"

Life-Sciences-Europe.com is your doorway to the European life sciences!

[LSE] provides free, up-to-date and structured access to

– News
– Products
– Persons
– Organisations
– Financings
– Collaborations


in Europe and Israel.

Access is unrestricted and free, requiring no log in and no user registration.The high-quality content is not related to the advertising, with topical relevance being the criterion for inclusion. [LSE] is 100% Made in Germany!

Start here with the latest News!

Advertisement

To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«

To get even more information, please take a look at our [gs] professional services offering and read the gene-sensor Product Flyer [PDF file]

Advertisement

» top

» Imprint  |  » Data Privacy  |  » Contact  |  The use of this website requires to accept the » Disclaimer!   |  A project of [iito] Business Intelligence © 2002-2020. Made in Germany.